Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

7 results for Pharmaceuticals
CLEAR ALL
Actylis
Excipients for injectable formulations. It is recommended for pharmaceutical applications like haemodialysis.Benefits:
  • Acts as buffering agents/pH modifiers
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc) 
Actylis
Excipient developed for pharmaceutical injectable formulations. Benefits:
  • Odorless powder
  • Assay: 99.8%
  • Complies with CDMF and USP specifications
Actylis
Buffering agent and pH modifier developed exclusively for use in injectable formulations.Benefits:
  • DMF Filed - CDE # F20200000141
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
Actylis
Solvent and co-solvent designed for injectable formulations. This excipient is used as a buffering agent and pH modifier. Benefits:
  • Highly pure, gives sweet taste
  • Helps to maintain low level of endotoxins and metallic impurities
  • Complies with CDMF, USP, Ph Eur specification
Actylis
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20190000639
Actylis
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
  • It maintains low level of endotoxins with the bioburden limits- BET/MLT
  • Controlled metallic impurities
  •  Developed for…
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189